News

2010-02-18
KAROLINSKA DEVELOPMENT: EMEA Recommends Orphan Drug Designation for Acute Myeloid Leukemia treatment

2010-01-26
Eribis Pharmaceuticals Receives Investment for Clinical Development of Novel Cardiovascular Therapy

2010-01-14
Karolinska Development and Uminova Invest Sign Co-operation Agreement

2010-01-14
Karolinska Development Expands its Life Science Portfolio with BioChromix Pharma

2009-12-21
Karolinska Development New Share Issue Completed – Raising 380 MSEK (36 MEUR)

2009-12-03
Aprea to Present Preclinical Data and an Update From the Clinical PhaseI/IIa Cancer Study on APR‐246 at the American Society of Hematology Annual Meeting in New Orleans, USA.

2009-12-03
Pharmasurgics to begin Phase II Clinical Trial for Prevention of Post‐Surgical Adhesions

2009-12-02
Dermagen Reports Successful Phase I/IIa Clinical Trial for AtopicDermatitis

2009-11-30
Pergamum appoints Jørgen Thorball as New Chairman of the Board

2009-11-25
Aprea AB Receives Allowance of a Key Patent in US and Europe

2009-11-20
Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation

2009-11-13
Axelar AB Presents the New Anticancer Agent AXL1717 at The AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston, Massachusetts, USA.

2009-11-09
Karolinska Development Invest in Lipidor AB

2009-10-14
Athera Receives Allowance of Two Key Patents

2009-10-13
Potential Treatment for Severe Malaria Completes Phase I Study

2009-09-30
Karolinska Development AB Announces New Share Issue

2009-09-24
New Cardiovascular Biomarker Available for Scientist in North America

2009-09-10
Pergamum to Provide Effective Development of Innovative Dermatology and Wound Healing Companies

2009-09-09
Karolinska Development Introduces New Concept for Development of its Dermatology and Wound Healing Portfolio

2009-09-04
Karolinska Development Portfolio Company Completes Successful Phase II Clinical Trial

2009-09-03
Promising Results from Phase II Trial Show New Treatment from Dilafor Prevents Protracted Labor in Childbirth

2009-08-24
Karolinska Development Portfolio Company Launches GMP Facility for Particulate Manufacturing

2009-08-20
XSpray launches GMP production facility

2009-08-06
Omnio Healer Selects Eden Biodesign for cGMP Production of its Candidate Wound Healing and Anti-Infection Treatments

2009-07-14
Novel Product for the Prevention of Post-Surgical Adhesion Formation Completes Phase I Clinical Study

2009-07-06
DermaGen completes patient enrolment for Phase I/IIa clinical trial

2009-07-03
BioCis Pharma Reports Positive Phase IIa Clinical Results in Atopic Dermatitis

2009-05-28
BioCis Pharma Starts a Phase I Clinical Trial with a New Cancer Drug

2009-05-06
Successful Phase I/II Clinical Trial Results from Cancer Patients Treated with Anticancer Drug from Axelar AB.

2009-04-29
Cardiovascular and Alzheimer therapy project wins VINNOVA grant

2009-03-13
Biovitrum enters agreement with Karolinska Development

2009-03-12
BioCis Pharma starts Phase IIa trial in psoriasis

2009-02-06
New Study in Science Uses Cogmed Working Memory Training to Reveal that Mental Activity can Impact the Brain’s Biochemistry

2009-01-21
Novel product for post surgical scar formation entering clinical development.

2009-01-21
Richter-Helm and Athera Biotechnologies Partner in Development of Recombinant Protein to Treat Cardiovascular Disease

2009-01-12
Karolinska Development Invests in EvoStem Finland Oy

2009-01-08
Karolinska Development Closes Fully Subscribed New Share Issue

2008-11-25
Atherosclerosis vaccine study wins VINNOVA grant

2008-11-20
Strong start to sales of Karolinska Development's New Share Issue

2008-11-13
Karolinska Development Strengthens its Management Team with the Appointment of Dr Carl Harald Janson

2008-11-05
BioCis Pharma Begins Phase IIa Trial in Atopic Dermatitis

2008-11-03
Invitation to Invest

2008-10-02
Xalieve™ Gains Momentum as Calabar AB Launches a Phase II Repeated Dose Study in Dry Mouth Patients

2008-10-02
Athera Biotechnologies and Dyax Announce a Collaboration to Discover and Develop Antibodies for Cardiovascular Inflammation

2008-09-09
BioCis Pharma Receives 1.6 Million EURO New Financing to Speed the Clinical Phase I/II Programme of the Company’s Dermatology Product.

2008-09-01
Calabar AB today announced new financing for continuation of the phase II program in patients with dry mouth

2008-07-29
Athera Biotechnology Founder Johan Frostegard and His Colleagues Win Distinguished Abstract Award

2008-06-17
Dr. Conny Bogentoft will be Presenting ‘Technology Transfer at the Karolinska Institutet’ at Bio2008

2008-06-17
Axelar Initiates Phase I/II Clinical Trial on Cancer Patients With the New Anti-Cancer Drug AXL1717

2008-06-12
Axelar Receives Financing For A Phase I/II Clinical Trial On Cancer Patients

2008-05-26
Strong VC-trio Invest in PharmaSurgics Wound Healing Product

2008-06-11
Annual General Meeting of Karolinska Development AB (publ)

2008-04-02
DermaGen AB Receives Over 1 million Euros From a New Share Issue

2008-04-04
IMED licenses technology from Medarex for fully human monoclonal antibodies

2008-03-04
BioCis Pharma has initiated a first-in-man study with ProtoCure™ emulsion cream

2008-05-01
Karolinska Development – an important new player in nordic life science

2008-02-05
Karolinska Institutet and Karolinska Development AB